MiNK Therapeutics (INKT) Live Share Price, Invest From India

MiNK Therapeutics Stock Performance

as on September 24, 2026 at 2:15 pm IST

Day's Low
Day's High
$11.68
Day's Price Range
$12.40
$12.35
5.43%
Downside
0.40%
Upside
52 Week's Low
52 Week's High
$8.48
52-Week Price Range
$16.93
$12.35
31.34%
Downside
37.06%
Upside

MiNK Therapeutics share price movements today

Previous Close: $12.11
Open: $12.25
Volume: 211.8K
Market Cap: $61.8M
Day's Low - High: $11.68 - $12.40
52 Week Low - High: $8.48 - $16.93

MiNK Therapeutics Historical Returns

1 Month Return: + 4.48 %
3 Month Return: + 1.98 %
1 Year Return: -13.88 %
3 Year Return: -5 %
5 Year Return: 0 %

MiNK Therapeutics Stock Fundamentals & Key Indicators

Check MiNK Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$61.8M

EPS (TTM)

-2.39

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-5.07

Industry PE ratio

-2.56

PEG Ratio

-0.29395702124726447

EBITDA

-11.3M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

83.45%

MiNK Therapeutics Stock Valuation

Track how MiNK Therapeutics P/E has moved over time to understand its valuation trends.

MiNK Therapeutics in the last 5 years

Overview
Trends

Lowest (-4.94x)

December 31, 2021

Today (-3.81x)

March 31, 2026

Industry (-2.56x)

March 31, 2026

Highest (-1.64x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -3.81x

MiNK Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of MiNK Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
MiNK Therapeutics	Buy	$61.8M	NA	-5.07	0.00%	0.00%
Moderna	Neutral	$72.9B	-57.66%	-22.88	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$-	180.48%	29.73	86.04%	0.00%
Regeneron	Buy	$82.2B	25.5%	19.2	84.86%	0.46%

Stock Returns calculator for MiNK Therapeutics Stock including INR - Dollar returns

The MiNK Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

MiNK Therapeutics investment value today

Current value as on today

₹92,845

Returns

-₹7,155

(-7.15%)

Returns from MiNK Therapeutics Stock

-₹13,877 (-13.88%)

Dollar Impact

₹6,722 (+6.72%)

Analyst Recommendation on MiNK Therapeutics Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for MiNK Therapeutics. Average target price of $39

MiNK Therapeutics Share Price Target

Get share price movements and forecasts by analysts on MiNK Therapeutics.

What analysts predicted

68.33%UPSIDE

Target Price

$39

Current Price

$12.35

Analyzed by

10 Analysts

Target

$39.00

MiNK Therapeutics target price $39, a slight upside of 68.33% compared to current price of $12.35. According to 10 analysts rating.

Indian Investors' Interest in MiNK Therapeutics Stock

Search interest for MiNK Therapeutics Stock has decreased by -46% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 25, 2026 to September 24, 2026

Change:-46% versus previous 30 day period

MiNK Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-5	-3	-2	-1	-2	-2	-3	-2	-2	-3
EBITDA	-5	-3	-2	-1	-2	-2	-4	-2	-2	-3
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-5	-3	-2	-1	-2	-2	-4	-2	-2	-3
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-5	-3	-2	-1	-2	-2	-4	-2	-2	-3
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

MiNK Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Mar 2026
Total Revenue	0	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0
Operating Income	-22	-10	-18	-30	-22	-10	-12
EBITDA	-22	-13	-27	-27	-22	-10	-12
Interest Expense	1	2	2	0	-	-	-
Depreciation	0	0	0	0	0	0	0
Income Before Tax	-23	-16	-30	-27	-22	-10	-12
Income Tax Expense	-	-	-	-	-	-	-
Net Income	-23	-16	-30	-27	-22	-10	-12
Net Profit Margin	100.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

MiNK Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026	Jun 2026
Net Income	-5	-3	-2	-1	-2	-2	-4	-2	-2	-3,128
Operating Cash Flow	-3	-2	-2	-2	-1	-1,340	-1	0	-1	-2,082
Investing Cash Flow	-	-	-	-	-	-	-	-	-	-
Financing Cash Flow	0	5	5	0	0	0	0	13	-2	1,366
Change in Cash	-3	2	3	-2	-1	-1,342	-1	12	-3	-718

MiNK Therapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Mar 2026
Net Income	-23	-16	-30	-27	-22	-10	-12
Operating Cash Flow	-14	-8	-12	-18	-15	-9	-5
Investing Cash Flow	0	0	0	0	0	-	-
Financing Cash Flow	11	11	49	0	0	10	14
Change in Cash	-4	2	36	-19	-16	1	8

Mutual Funds that own MiNK Therapeutics Stock

Check out the Mutual Funds with significant holdings in MiNK Therapeutics.

Funds	Holdings	Shares Held
VANGUARD INDEX FUNDS	1.163315%	59364
Fidelity Concord Street Trust	0.231843%	11831

Global Institutional Holdings in MiNK Therapeutics

Funds	Holdings
Vanguard	1.34%
VANGUARD INDEX FUNDS	1.16%
Fidelity Concord Street Trust	0.23%
iShares	0.13%

Insights on MiNK Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, -11.70B → 3.76B (in $), with an average increase of 410.6% per quarter
POSITIVE IMPACT
Price Rise
In the last 7 days, INKT stock has moved up by 5.5%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 603.7% return, outperforming this stock by 617.6%
NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 82.1% return, outperforming this stock by 87.1%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -2.60M → -3.12M (in $), with an average decrease of 9.7% per quarter

About MiNK Therapeutics

MiNK Therapeutics, Inc. is a biopharmaceutical firm currently undergoing clinical trials. Its primary focus is on the identification, advancement, and market introduction of innovative invariant natural killer T (iNKT) cell therapies. These treatments are allogeneic and designed to be "off-the-shelf," providing readily available options for combating various cancers and conditions rooted in immune system dysfunction. The company's leading investigational therapy is AGENT-797. This product is an allogeneic, ready-to-use iNKT cell therapy, presently in Phase 1 clinical studies to assess its effectiveness against different forms of myeloma. Established in 2017, the company was previously known as AgenTus Therapeutics, Inc. MiNK Therapeutics, Inc. is headquartered in New York, New York, and operates as a subsidiary of Agenus Inc.

Organisation	MiNK Therapeutics
Headquarters	149 Fifth Avenue, New York City, NY, 10010, US
Industry	Biotechnology
CEO	Jennifer S. Buell
E-voting on shares	Click here to vote

Key Management of MiNK Therapeutics

Name	Title
Dr. Jennifer S. Buell Ph.D.	Co-Founder, President, CEO & Director
Ms. Melissa Orilall	Principal Financial Officer
Mr. Austin Charette	Principal Accounting Officer
Dr. Terese C. Hammond M.D.	Head of Inflammatory & Pulmonary Diseases
Dr. Marco Purbhoo	Head of Translational Medicine
Dr. Garo H. Armen Ph.D.	Executive Chairman

FAQs

What is MiNK Therapeutics share price today?

MiNK Therapeutics share price today is $12.35 as on September 24, 2026 at 8:45 am IST at the close of the market. MiNK Therapeutics share today touched a day high of $12.40 and a low of $11.68.

What is the 52 week high and 52 week low for MiNK Therapeutics share?

MiNK Therapeutics share touched a 52 week high of $16.93 on March 10, 2026 and a 52 week low of $8.48 on March 24, 2026. MiNK Therapeutics stock price today i.e. September 24, 2026 at 8:45 am IST is closed at $12.35,which is 27.04% down from its 52 week high and 45.64% up from its 52 week low.

What is MiNK Therapeutics's market capitalisation today?

MiNK Therapeutics market capitalisation is $0.00T as on September 24, 2026 at 8:45 am IST.

How to invest in MiNK Therapeutics Stock (INKT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for MiNK Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in MiNK Therapeutics Shares that will get you 0.1215 shares as per MiNK Therapeutics share price of $12.35 per share as on September 24, 2026 at 8:45 am IST.

What is the minimum amount required to buy MiNK Therapeutics Stock (INKT) from India?

Indian investors can start investing in MiNK Therapeutics (INKT) shares with as little as ₹95.74 or $1 (as of September 24, 2026 at 3:47 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹957.40 in MiNK Therapeutics stock (as per the Rupee-Dollar exchange rate as on September 24, 2026 at 3:47 pm IST). Based on MiNK Therapeutics share’s latest price of $12.35 as on September 24, 2026 at 8:45 am IST, you will get 0.8097 shares of MiNK Therapeutics. Learn more about fractional shares .